Advertisement
BEAT vs VEEV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAT is a Buy and VEEV is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BEAT’s FA Score shows that 1 FA rating(s) are green whileVEEV’s FA Score has 0 green FA rating(s).
- BEAT’s FA Score: 1 green, 4 red.
- VEEV’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BEAT’s TA Score shows that 4 TA indicator(s) are bullish while VEEV’s TA Score has 4 bullish TA indicator(s).
- BEAT’s TA Score: 4 bullish, 6 bearish.
- VEEV’s TA Score: 4 bullish, 5 bearish.
Price Growth
BEAT (@Services to the Health Industry) experienced а +21.32% price change this week, while VEEV (@Services to the Health Industry) price change was +0.08% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.78%. For the same industry, the average monthly price growth was -6.36%, and the average quarterly price growth was +5.85%.
Reported Earning Dates
BEAT is expected to report earnings on Mar 19, 2026.
VEEV is expected to report earnings on Mar 04, 2026.
Industries' Descriptions
@Services to the Health Industry (+0.78% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| BEAT | VEEV | BEAT / VEEV | |
| Capitalization | 24.8M | 39.5B | 0% |
| EBITDA | -20.53M | 839M | -2% |
| Gain YTD | -69.270 | 14.216 | -487% |
| P/E Ratio | N/A | 46.81 | - |
| Revenue | 0 | 2.97B | - |
| Total Cash | 5.05M | 6.4B | 0% |
| Total Debt | N/A | 85.4M | - |
BEAT | VEEV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 87 | 58 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 89 Overvalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 56 | |
PRICE GROWTH RATING 1..100 | 96 | 64 | |
P/E GROWTH RATING 1..100 | 5 | 71 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
VEEV's Valuation (78) in the Packaged Software industry is in the same range as BEAT (89) in the Medical Specialties industry. This means that VEEV’s stock grew similarly to BEAT’s over the last 12 months.
VEEV's Profit vs Risk Rating (100) in the Packaged Software industry is in the same range as BEAT (100) in the Medical Specialties industry. This means that VEEV’s stock grew similarly to BEAT’s over the last 12 months.
VEEV's SMR Rating (56) in the Packaged Software industry is somewhat better than the same rating for BEAT (100) in the Medical Specialties industry. This means that VEEV’s stock grew somewhat faster than BEAT’s over the last 12 months.
VEEV's Price Growth Rating (64) in the Packaged Software industry is in the same range as BEAT (96) in the Medical Specialties industry. This means that VEEV’s stock grew similarly to BEAT’s over the last 12 months.
BEAT's P/E Growth Rating (5) in the Medical Specialties industry is significantly better than the same rating for VEEV (71) in the Packaged Software industry. This means that BEAT’s stock grew significantly faster than VEEV’s over the last 12 months.
| BEAT | VEEV | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 74% |
| Stochastic ODDS (%) | 2 days ago 84% | 2 days ago 77% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 63% |
| MACD ODDS (%) | N/A | 2 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 61% |
| Advances ODDS (%) | 5 days ago 84% | 7 days ago 65% |
| Declines ODDS (%) | 8 days ago 88% | 9 days ago 64% |
| BollingerBands ODDS (%) | 2 days ago 89% | 2 days ago 71% |
| Aroon ODDS (%) | 2 days ago 90% | N/A |
Advertisement
BEAT and
Correlation & Price change
A.I.dvisor indicates that over the last year, BEAT has been loosely correlated with SNOW. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BEAT jumps, then SNOW could also see price increases.
| Ticker / NAME | Correlation To BEAT | 1D Price Change % | ||
|---|---|---|---|---|
| BEAT | 100% | -1.83% | ||
| SNOW - BEAT | 37% Loosely correlated | +3.05% | ||
| APPN - BEAT | 33% Poorly correlated | +2.27% | ||
| MNDY - BEAT | 32% Poorly correlated | -0.87% | ||
| ZS - BEAT | 31% Poorly correlated | -0.66% | ||
| VEEV - BEAT | 31% Poorly correlated | -0.11% | ||
More | ||||